Most of the disease-causing mutations that science has been able to identify so far are located within the exons. Whereas most genetic tests focus on a single gene or on a set number of predetermined genes, whole exome sequencing examines thousands of genes simultaneously.
Articles on Whole Exome Sequencing
-
Whole Exome and Whole Genome Sequencing Course September 2019
Gaining deep insights about WES/WGS workflow from lab to report and benefit from experiences via hands-on courses supervised by our experts. Take the unique opportunity to discuss with our experts and exchange with others from the field!
-
Biallelic variants in the transcription factor PAX7 are a new genetic cause of myopathy
Disease expressivity varies widely in many genetic disorders, and identifying the underlying modifiers holds great translational potential. Based on its resources as regards technologies and samples, CENTOGENE is uniquely positioned to significantly contribute to pertinent efforts. One recent…
-
Whole Exome and Whole Genome Sequencing Course May 2019
Gaining deep insights about WES/WGS workflow from lab to report and benefit from experiences via hands-on courses supervised by our experts. Take the unique opportunity to discuss with our experts and exchange with others from the field!
-
A homozygous frameshift variant in an alternatively spliced exon of DLG5 causes hydrocephalus and renal dysplasia
Based on the ambition to provide maximum diagnostic yield, CENTOGENE offers follow up of negative WES/WGS reports in a research setting. Recently, this approach resulted in the association of a special form of congenital hydrocephalus with bi-allelic inactivation of the DLG5 gene. The finding, which…
-
Utility and implications of exome sequencing in early-onset Parkinson's disease.
Although the genetic load is high in early-onset Parkinson’s disease, thorough investigation of the genetic diagnostic yield has yet to be established. The objectives of this study were to assess variants in known genes for PD and other movement disorders and to find new candidates in 50 patients…